Filter
673
Text search:
World
Health
Organization,
Stop
TB
Partnership
Featured
Recommendations
51
New Publications
186
Language
Document type
No document type
496
Studies & Reports
73
Guidelines
48
Strategic & Response Plan
23
Manuals
21
Fact sheets
6
Training Material
4
Brochures
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
26
Kenya
21
India
20
Global
19
Nepal
18
Eastern Europe
18
Rwanda
15
Bangladesh
14
Liberia
13
Uganda
13
Zambia
13
Ethiopia
12
Asia
12
Tanzania
11
South Africa
11
Myanmar / Burma
11
Cambodia
10
Malawi
9
Nigeria
8
Sierra Leone
7
Ukraine
7
Latin America and the Carribbean
7
Ghana
6
Philippines
6
Mozambique
6
Botswana
6
Indonesia
5
South–East Asia Region
5
Senegal
4
Zimbabwe
4
Namibia
4
Africa
4
Pakistan
3
Germany
3
Lesotho
3
Timor Leste/ East Timor
3
Russia
3
Guinea
2
Congo, Democratic Republic of
2
South Sudan
2
Thailand
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Sri Lanka
2
Bhutan
2
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Afghanistan
1
Syria
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Dominican Republic
1
Burundi
1
Honduras
1
El Salvador
1
Guatemala
1
Nicaragua
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
North Korea
1
Albania
1
Armenia
1
Southern Africa
1
Laos
1
Tajikistan
1
Bulgaria
1
Vietnam
1
Maldives
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
243
Clinical Guidelines
43
Public Health
22
Women & Child Health
11
Pharmacy & Technologies
11
Key Resources
10
Capacity Building
2
Toolboxes
TB
270
HIV
90
COVID-19
16
Health Financing Toolbox
15
Polio
14
AMR
12
NTDs
9
Caregiver
8
Ebola & Marburg
7
Conflict
6
Refugee
6
Global Health Education
6
Pharmacy
6
Disability
5
Natural Hazards
5
Rapid Response
4
Planetary Health
3
NCDs
3
Malaria
3
Mental Health
2
Cholera
1
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The Strategic Malaria Communication Guide for Central America is intended to facilitate the shift from malaria control to elimination by strengthening communication and advocacy initiatives throughout the region. Based on interviews and a review of literature, the guide offers National Malaria Progr
...
The Government of Republic of Zambia reported the first confirmed cases of COVID-19 on 18th March 2020. As of April 27th, 2020, there were 89 confirmed cases, three deaths and 42 recoveries. Confirmed cases are located in three provinces: Lusaka (83 cases), Copperbelt province (5 cases) and Central
...
The Government of Republic of Zambia reported the first confirmed cases of COVID-19 on 18th March 2020. As of April 27th, 2020, there were 89 confirmed cases, three deaths and 42 recoveries. Confirmed cases are located in three provinces: Lusaka (83 cases), Copperbelt province (5 cases) and Central
...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Информационный бюллетень, учет потребностей подростков. Подростки имеют особые потребности в области медицинских услуг, включая доступ к профилактической помощи
...
Accessed: 08.10.2019
Как и руководство 2006 года, настоящий документ предназначен для специалистов,
занимающихся разработкой государственных программ по борьбе с туберкулезом, педиатр
...
Для создания этого отчета MSF исследовала программы и практику лечения лекарственно-чувствительного и лекарственно-устойчивого туберкулеза в восьмистранах с высо
...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co
...
3rd Edition – July 2017
www.msfaccess.org
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India